Analysis of the benefit of gonadotropin-releasing hormone agonist treatment in premenopausal women undergoing hematopoietic cell transplantation

Gonadotropin-releasing hormone agonist (GnRHa) appears to exhibit ovarian protection during chemotherapy for malignant tumors. The purpose of this study was to analyze the benefits of GnRHa in premenopausal women undergoing hematopoietic cell transplantation (HSCT). Candidates for myeloablative chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Ruxue, Song, Ziyi, Li, Huiling, Wang, Chaohua, Zhang, Leping, Yang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477207/
https://www.ncbi.nlm.nih.gov/pubmed/37666835
http://dx.doi.org/10.1038/s41598-023-40778-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477207/
https://www.ncbi.nlm.nih.gov/pubmed/37666835
http://dx.doi.org/10.1038/s41598-023-40778-2

Ejemplares similares